Scientific Sessions

Drug delivery plays a pivotal role in advancing cancer treatment and immune-based therapies. This track focuses on innovative delivery platforms such as nanoparticles, liposomes, micelles, hydrogels, and antibody-drug conjugates that improve tumor targeting, therapeutic efficacy, drug stability, and reduce toxicity, safety profiles. It also highlights drug delivery with immunotherapy approaches, including immune checkpoint inhibitors, cancer vaccines, monoclonal antibodies, and CAR-T cell therapies to enhance precision, reduce systemic toxicity, and overcome resistance mechanisms. Applications range from solid tumors to hematological cancers, focusing on precision medicine, personalized therapies, and overcoming resistance mechanisms to bring cutting-edge science closer to patient care.